Guidelines on the management of osteoporosis associated with chronic liver disease.
Collier
Jane D
JD
Department of Gastroenterology, John Radcliffe Hospital, Oxford, OX3 9DU, UK. Jane.Collier@orh.nhs.uk
Ninkovic
M
M
Compston
J E
JE
D015415:Biomarkers; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000008:administration & dosage; D002908:Chronic Disease; D019587:Dietary Supplements; D004164:Diphosphonates / Q000627:therapeutic use; D004338:Drug Combinations; D050723:Fractures, Bone / Q000209:etiology; D020249:Hormone Replacement Therapy / Q000379:methods; D006801:Humans; D008107:Liver Diseases / Q000150:complications*; D010024:Osteoporosis / Q000150:complications / Q000628:therapy*; D012307:Risk Factors; D013256:Steroids / Q000627:therapeutic use; D014807:Vitamin D / Q000008:administration & dosage
D015415:Biomarkers; D004164:Diphosphonates; D004338:Drug Combinations; D013256:Steroids; D014807:Vitamin D; D002116:Calcitonin; D002118:Calcium